Women are diagnosed with MS about twice as often as men, but the reason involves multiple overlapping factors rather than a single cause
Multiple sclerosis affects women at roughly double the rate it affects men, and this gap has widened over the past few decades. The disease itself—where the immune system attacks nerve coverings in the brain and spinal cord—works the same way in both sexes. But something about being female makes the immune system more likely to mount this attack in the first place. Researchers have identified several factors that appear to play a role: hormones, genetics, infections, and possibly environmental exposures. None of these alone explains why women are at higher risk. The most likely answer is that MS develops when several of these factors overlap in the same person.
This matters because it means MS in women is not caused by a single preventable thing. A woman did not develop MS because she smoked, or lacked vitamin D, or caught a particular virus. Rather, her particular combination of genetics, infections, hormones, and environment created the conditions for the disease to develop. Understanding this distinction helps explain why prevention is not straightforward and why two women with similar risk factors may have very different outcomes.
Key Takeaways
- Women are diagnosed with MS roughly twice as often as men, though the reason involves multiple overlapping factors rather than a single cause.
- Hormonal differences, particularly estrogen levels and how they fluctuate during menstruation and pregnancy, appear to influence MS risk in ways that are still being studied.
- Genetic variations that make the immune system more reactive are more common in women, but genes alone do not determine who develops MS.
- Certain viral infections, particularly Epstein-Barr virus, are linked to MS risk and may trigger the disease in people who are genetically susceptible.
- Smoking, obesity, vitamin D deficiency, and living far from the equator are environmental factors associated with higher MS risk in both sexes, but the effect may be stronger in women.
How hormones may increase MS risk in women
Estrogen and progesterone influence how the immune system responds to threats. Women have higher baseline estrogen levels than men, and these levels shift throughout the menstrual cycle, during pregnancy, and at menopause. Some research suggests that estrogen can make immune cells more active and more likely to attack the body's own tissues. Other studies find that estrogen can also calm immune responses, depending on the dose and the type of immune cell involved. This contradiction reflects how little is still known about the hormone-immunity connection.
Pregnancy offers a clue. Many women with MS experience fewer relapses during pregnancy, particularly in the third trimester when estrogen levels are highest. After delivery, relapses often increase again. This pattern suggests that high, stable estrogen may protect against MS activity, while fluctuating levels—as occur during menstruation or after childbirth—may trigger it. Hormonal contraceptives and hormone replacement therapy also affect MS risk, though research on whether they increase or decrease it remains mixed and depends on the specific formulation and dose.
Genetic differences that make women's immune systems more reactive
MS is not inherited in a straightforward way, but people with certain genetic variations are at higher risk. Many of these variations affect how immune cells recognize and respond to threats. Women and men can carry the same genetic risk factors, but women appear more likely to develop MS even when they have them. This suggests that genes create the potential for MS, but something about being female—likely hormones or other sex-specific biology—tips the balance toward disease.
One genetic difference involves the X chromosome. Women have two X chromosomes while men have one X and one Y. This means women can carry two different versions of genes on the X chromosome, while men carry only one. Some researchers believe this difference in X chromosome genetics may make women's immune systems more variable and potentially more prone to autoimmune disease. However, this theory remains under investigation and does not fully explain the female predominance in MS.
Epstein-Barr virus and other infections linked to MS
Nearly all people with MS have been infected with Epstein-Barr virus (EBV), the virus that causes mononucleosis. Most people who get EBV never develop MS, but the infection appears to be a necessary step in the disease process. The virus may trigger MS by causing immune cells to attack nerve coverings that resemble viral proteins, or by causing long-term changes in how the immune system functions. Women and men are infected with EBV at similar rates, so this alone does not explain why women develop MS more often.
Other infections have also been studied as possible MS triggers, including cytomegalovirus and human herpesvirus 6. The timing of infection may matter—getting EBV as a teenager or adult rather than in childhood appears to increase MS risk. Whether women are more susceptible to these infections, or whether their immune systems respond differently to them, is not yet clear. The current understanding is that infection is one piece of the puzzle, not the whole picture.
Environmental and lifestyle factors that may affect women differently
Smoking, obesity, vitamin D deficiency, and living far from the equator are all associated with higher MS risk in both women and men. Sunlight exposure influences vitamin D production in the skin, which may explain why MS is more common in northern latitudes. Smoking damages the immune system's ability to regulate itself. Obesity increases inflammation throughout the body. Yet women diagnosed with MS are more likely to have had these exposures than men with MS, suggesting that women may be more vulnerable to their effects.
The reason for this difference is unclear. It may be that women's immune systems are inherently more reactive and therefore more easily pushed toward autoimmunity by environmental triggers. It may also be that women are more likely to experience certain exposures—for example, some research suggests women are more likely to be deficient in vitamin D. Or the difference may reflect how hormones interact with environmental factors. A woman's vitamin D status, for instance, may affect estrogen levels, which in turn affects immune function. Teasing apart these overlapping influences remains an active area of research.
Why MS develops when multiple factors align
The current scientific model of MS is that the disease requires a combination of genetic susceptibility, immune system activation (often from infection), and environmental or hormonal triggers. A woman might carry genetic variations that make her immune system more reactive, be infected with EBV, have low vitamin D, and experience hormonal fluctuations—and the overlap of these factors tips her toward MS. Another woman with the same genetic variations but different exposures might never develop the disease. This explains why MS runs in families but is not inherited in a predictable way, and why two people with identical genetic risk can have very different outcomes.
The female predominance in MS likely reflects the fact that women's immune systems are, on average, more active and more prone to autoimmune responses. This same trait that increases MS risk also means women's immune systems are generally better at fighting infections and may contribute to women's longer average lifespan. The biological mechanisms that protect women in some contexts may increase their vulnerability to autoimmune disease in others.
What this means for women diagnosed with MS
Understanding that MS develops from multiple overlapping factors means that no single cause can be blamed or prevented. A woman diagnosed with MS did not get the disease because she smoked, or because she was deficient in vitamin D, or because she had EBV. Rather, her particular combination of genetics, infections, hormones, and environment created the conditions for MS to develop. This distinction matters because it means prevention strategies are not straightforward, and a woman's choices before diagnosis did not cause her disease.
After diagnosis, some of these factors become relevant to treatment decisions. Hormonal contraceptives and pregnancy planning may need to be discussed with a neurologist because hormones affect MS activity. Vitamin D levels can be checked and corrected. Smoking cessation is recommended. But these steps are about managing the disease going forward, not about reversing or preventing what has already happened. The underlying reason why women develop MS more often than men remains an open question that researchers continue to investigate.
Frequently Asked Questions
Does MS run in families, and are women more likely to inherit it?
MS is not inherited in a simple way. Having a family member with MS increases your risk, but most people with MS do not have a family history of the disease. Women and men with family histories of MS have similar increased risks. However, women are more likely to be diagnosed overall, so in any given family, female relatives may be more likely to develop the disease than male relatives.
Can pregnancy prevent or cure MS?
Pregnancy does not prevent or cure MS, but it often reduces relapses during the nine months of pregnancy, especially in the third trimester. After delivery, relapses typically increase again. Some women experience significant changes in their MS activity around pregnancy, while others notice little difference. These changes are individual and unpredictable.
Does taking hormonal contraceptives increase MS risk?
Research on hormonal contraceptives and MS risk is mixed. Some studies suggest certain formulations may increase risk slightly, while others find no clear link. If you have MS or a family history of MS and are considering contraception, discussing options with your neurologist and gynecologist is worthwhile, as they can weigh the risks and benefits for your specific situation.
If I have low vitamin D, will I develop MS?
Low vitamin D is associated with higher MS risk, but it does not cause MS on its own. Many people with low vitamin D never develop MS. If you have MS, maintaining adequate vitamin D levels may help with disease management. If you have a family history of MS, checking and correcting vitamin D deficiency is a reasonable precaution, though it is not may provide to prevent disease.
Why do some women get MS and others with the same risk factors do not?
MS appears to require a specific combination of genetic, immune, infectious, and environmental factors that differs from person to person. Two women might share some risk factors but differ in others—one might have EBV infection and low vitamin D but protective genes, while another has genetic risk but avoided EBV infection. The particular mix that triggers MS in one person may not occur in another.